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In Brief
 
Mechanism of Rabies Virus–
induced Membrane Fusion
 
Gaudin (page 601) used a liposome
 
assay to determine the sensitivity
of rabies virus–induced membrane
fusion to lysophosphatidylcholine
(LPC) and oleic acid. The effects of
 
these lipids on the rabies virus–
induced fusion pathway are similar to
their effects in other fusion systems,
supporting the idea that all biological
membrane fusion events proceed by
the same pathway.
 
Although extensive work on influ-
enza virus–induced membrane fusion
and theoretical models of the energet-
ics of lipid structures have led to the
proposal that membrane fusion pro-
 
ceeds by a universal pathway, this theory
has only been tested in a small num-
ber of systems. In the new work, the
 
author focused on rabies virus–induced
membrane fusion, which differs from
influenza virus–induced fusion in sev-
eral respects. The response of the ra-
bies virus fusion event to LPCs with
alphatic side chains of varying length,
and to oleic acid, demonstrates that
rabies virus and influenza virus–induced
fusion follow similar pathways.
 
In both cases, fusion begins with
the insertion of a fusion peptide into
the target membrane, which then in-
duces the formation of a stalk struc-
ture connecting the viral and target
membranes. The stalk then expands,
and the inner leaflets of the mem-
branes form a hemifusion diaphragm,
which then forms a pore that expands
and completes the fusion process. The
ability to make direct comparisons
between structurally diverse mem-
brane fusion systems should facilitate
higher resolution studies of mem-
brane dynamics.
 
New View of
Microfibril Assembly
 
Using a combination of genetic
crosses and cell culture assays,
Gayraud et al. (page 667) have devel-
oped a new model to explain the phe-
 
notype of 
 
Tight skin
 
 (
 
Tsk
 
) mutant
mice, which carry a mutation in the
fibrillin 1 (
 
Fbn1
 
) gene. In addition to
providing a new perspective on the
assembly of extracellular microfibrils,
the data help to explain the discrep-
ancies between 
 
Tsk
 
 mutant mice and
Marfan syndrome, a human genetic
disorder. Like Marfan syndrome pa-
tients, mice with reduced 
 
Fbn1
 
 gene
expression exhibit lung emphysema,
bone overgrowth, and vascular com-
 
plications. Heterozygous 
 
Tsk
 
/
 
1
 
 mice,
which express a mutant 
 
Fbn1
 
 gene
product at normal levels, display lung
emphysema and bone overgrowth,
but lack the vascular complications
typical of Marfan syndrome and the
other mouse models.
 
In the new work, the authors dem-
onstrate that Tsk fibrillin 1 copoly-
merizes with wild-type fibrillin 1, in
 
contrast to earlier models which sug-
gested the formation of two distinct
 
pools of microfibrils in 
 
Tsk
 
/
 
1
 
 mice.
Instead, Tsk fibrillin 1 molecules ap-
pear to participate in the initial stages
of microfibril assembly, but can only
yield long microfibrils by copolymer-
izing with wild-type fibrillin 1. The re-
sults suggest that copolymerization
produces functionally deficient mi-
crofibrils, decreasing the level of func-
tional microfibrils below the threshold
necessary to cause Marfan syndrome-
like bone overgrowth and emphy-
sema, but not below the threshold for
vascular abnormalities.
 
Postmitotic Reassembly of
the Nucleolus
 
Beginning on page 433, Dundr et al.
describe the first examination of the
timing of postmitotic nucleolar reas-
sembly using GFP-tagged proteins in
living cells. The results support earlier
findings that postmitotic nucleoli in-
corporate assembled components de-
rived from the maternal cell, and also
provide temporal data that suggest a
detailed model of nucleolar assembly.
By following the localization of
 
GFP fusions of the processing-
related proteins fibrillarin, nucleolin,
 
and B23, they found that the nucle-
olus-derived foci (NDF), which con-
tain partially processed preribosomal
RNA in association with processing
components, disappear during telo-
phase. At the same time, the tagged
proteins begin to appear in the re-
forming nuclei of the daughter cells. 
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Prenucleolar bodies (PNBs), which
appear in nuclei in early telophase,
gradually disappear as the nucleoli
form, suggesting that the PNB com-
ponents are transferred to the form-
ing nucleoli.
Based on their results, the authors
propose a model in which pre-rRNA
transcripts, associated with processing
components, are transferred to post-
mitotic nuclei, where they become in-
corporated into PNBs. The processing
components are then transferred
from PNBs into the newly forming
nucleoli in a process that depends on
the reactivation of nucleolar tran-
scription. At the same time, reactiva-
tion of pre-rRNA processing also
seems to occur. The team is now hop-
ing to use the GFP-tagged compo-
nents to confirm the details of the
new model and to elucidate the regu-
latory mechanisms controlling nucle-
olar reassembly.
 
Visualizing tRNA Movements
 
Although several groups have ana-
lyzed the structure of tRNA bound to
the ribosome by cryo-electron micros-
copy (cryo-EM) and x-ray crystallog-
raphy, the functionally relevant pre-
and posttranslocation tRNA binding
sites on the ribosome have remained
uncertain. Agrawal et al. (page 447)
now report the development of cryo-
EM maps of tRNA–ribosome com-
plexes at a resolution of 17Å under
precisely controlled conditions, re-
vealing the principal positions of
tRNA through the course of the elon-
gation cycle.
The new results constitute the high-
est resolution three-dimensional cryo-
EM maps of tRNA-ribosome com-
plexes to date, and the carefully
controlled buffer conditions address a
problem discovered in earlier work:
tRNA positions can vary significantly
 
in different buffers. The team identi-
fied six different tRNA locations,
named A (before peptide bond forma-
tion), A
 
Pep
 
 (after bond formation), P,
P/E, E, and E2. Although some of the
site assignments agree with those pre-
viously described, Agrawal et al. also
identified several differences between
their results and those of earlier x-ray
and cryo-EM studies. Based on the ac-
cumulated structural data, the authors
present a detailed model of the main
events of the elongation cycle.
 
Tracks Define a New Step in 
mRNA Export
 
By examining the localization of
RNA transcribed from mutant and
wild-type COL1A1 genes in heterozy-
gous cells, Johnson et al. (page 417)
found that while mutant transcripts
initiate transport from the gene, they
are unable to exit the SC-35 domain
adjacent to the gene. In addition to
providing new information about the
molecular pathogenesis of osteogene-
sis imperfecta, the genetic disease as-
sociated with COL1A1 mutations, the
new results identify a previously un-
known step in mRNA export and may
help resolve the controversy over the
existence of RNA “tracks” in the nu-
cleus.
 
Nuclear RNA “tracks,” localized
accumulations of post-transcriptional
RNA, appear beside both the normal
and mutant COL1A1 genes. The nor-
mal COL1A1 RNA tracks are distrib-
uted throughout a large SC-35-con-
taining domain on one side of the
gene, and the transcripts are dis-
persed from the domain after splicing
is complete. Mutant transcripts ini-
tiate transport from the gene, but are
then retained within the SC-35 do-
main, identifying an early step in the
mRNA export pathway.
The results suggest that normal
COL1A1 mRNA generates a “track”
by moving from the gene into the ad-
jacent SC-35 domain, then disperses
from the domain into the nucleo-
plasm before reaching the nuclear en-
velope and being translocated into
the cytoplasm. Surprisingly, the
COL1A1 transcripts are predomi-
nantly spliced before they passage
through the splicing factor domain,
where they find evidence that further
maturation and release for export oc-
cur. The authors suggest that SC-35
domains associated with other genes
may function similarly.
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